Actively Recruiting
Model-informed Individualized Treatment of Anti-infective Drugs in Patients With Osteoarticular Infections
Led by Shandong University · Updated on 2024-12-02
300
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating how to optimize personalized treatment of anti-infective drugs for people with osteoarticular infections by studying drug levels in the blood and tissues. This observational study aims to better understand how these drugs behave in the body using population pharmacokinetics, which can help guide dosing decisions. Participants will receive anti-infective drugs following traditional clinical dosing without additional interventions. The study mainly observes and collects data on drug clearance and distribution over about 30 days. During the study, participants will have their drug exposure measured through blood or tissue samples. Researchers will also monitor markers like erythrocyte sedimentation rate and record any adverse events. The study lasts approximately 30 days to collect all relevant data for analysis.
CONDITIONS
Brief Title
Model-informed Individualized Treatment of Anti-infective Drugs
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with suspected or confirmed osteoarticular infections who are receiving anti-infective drug therapy
You will not qualify if you...
- Pregnant or breastfeeding women
- Any other factors that researchers consider unsuitable for participation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Approximately 30 days
Participants receive anti-infective drugs according to traditional clinical dosing regimens without additional interventions.
Visits scheduled as part of routine care
Duration - Up to 30 days
Participants are monitored for drug clearance, volume of distribution, and safety outcomes during and after treatment.
Visits scheduled as part of routine care
Trial Site Locations
Total: 1 location
1
Shandong Public Health Clinical Center
Jinan, China
Actively Recruiting
Research Team
W
Wei Zhao, Ph.D
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here